New Reach Of Pharma’s Hidden Hand: Hiding In Plain Sight
Big Pharma's influence on patient advocacy groups
June 2023 Cancer Drug Prices Report
The BURDEN of Cancer Drug Prices On Patients. The RELIEF in the Inflation Reduction Act.
Merith Basey Named Executive Director Of Patients For Affordable Drugs
Basey Has Devoted Her Career To Ensuring That Life-saving Medications Are Affordable And Accessible For All Who Need Them
JULY PRICE HIKES REPORT: Big Pharma’s Continued Greed Underscores Urgent Need For Reform To Lower Drug Prices
In The Third Year Of The Pandemic And As Americans Grapple With Record Inflation, Big Pharma Continues To Raise Prices And Exploit Patients
July 2022 Price Hikes Report
In The Third Year Of The Pandemic And As Americans Grapple With Record Inflation, Big Pharma Continues To Raise Prices And Exploit Patients
NEW REPORT: Big Pharma’s Lockstep Price Hikes On Widely Used Blood Thinners Exploit Patients And Taxpayers
A new report issued today documents how drug companies use their market and political power to avoid competition and raise prices in lockstep.
ELIQUIS AND XARELTO: LOCKSTEP PRICE HIKES AND PATENT GAMING EXPLOIT PATIENTS AND TAXPAYERS
This report examines the practices of BMS/Pfizer and Johnson & Johnson's lockstep price hikes and patent gaming on two blockbuster blood thinners and the implications for patients and taxpayers.
Round 2 Of January 2022 Hikes Pushes Blockbuster Prices To New Heights
Drug companies raised the prices of 742 drugs in January 2022
